All types of drugs are expected to be affected to lesser or greater degrees by the COVID-19 outbreak in South Korea in 2020. Antiviral and respiratory drugs, along with those used for treating life-threatening conditions are expected to be the least affected. In contrast, drugs for non-urgent illnesses and conditions are expected to be most affected, as people stay away from hospitals if possible.
Adjusted pharmaceutical sales forecast in South Korea in 2020, by drug type (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Changes in outpatient prescriptions in Gwangju and Jeolla South Korea 2020
- Impact of COVID-19 on revenue of hospitality and retail sector South Korea 2020
- Impact of COVID-19 on OTC pharmacy sales South Korea 2020
- Changes in outpatient prescriptions during COVID-19 in Seoul South Korea 2020
- Changes in outpatient prescriptions in Daegu and Gyeongbuk South Korea 2020
- Changes in outpatient prescriptions in Daejeon and Chungcheong South Korea 2020
- Changes in outpatient prescriptions in Busan and Gyeongnam South Korea 2020
- Impact of COVID-19 on pharmacy operations in South Korea 2020
- Changes in outpatient prescriptions in Gyeonggi/Incheon/Gangwon South Korea 2020
- Annual growth rate of pharmaceutical spending in Japan FY 2018-2024
- Growth rate of pharmaceutical sales value in China 2018-2023
- Forecasted growth rate of pharmaceutical sales value in China 2020, by quarter
- Sales value of pharmaceutical market in China 2018-2023
- Pharmaceutical spending Japan FY 2018-2024
- Forecasted quarterly sales value of pharmaceutical market in China 2020
- Impact of COVID-19 on inbound tourist arrivals South Korea 2020
- Coronavirus-related share price changes in biopharma companies Jan-Feb 2020
- Safest form of contact with the doctor during the COVID-19 pandemic in Poland 2020
- Night time economy business survival during COVID-19 in the UK 2020
- Opinion on possibility of Tokyo Olympics still being held after COVID-19 Japan 2020
IQVIA. (March 31, 2020). Adjusted pharmaceutical sales forecast in South Korea in 2020, by drug type (in billion South Korean won) [Graph]. In Statista. Retrieved July 06, 2022, from https://www.statista.com/statistics/1120102/south-korea-pharmaceutical-sales-forecast-by-drug-type/
IQVIA. "Adjusted pharmaceutical sales forecast in South Korea in 2020, by drug type (in billion South Korean won)." Chart. March 31, 2020. Statista. Accessed July 06, 2022. https://www.statista.com/statistics/1120102/south-korea-pharmaceutical-sales-forecast-by-drug-type/
IQVIA. (2020). Adjusted pharmaceutical sales forecast in South Korea in 2020, by drug type (in billion South Korean won). Statista. Statista Inc.. Accessed: July 06, 2022. https://www.statista.com/statistics/1120102/south-korea-pharmaceutical-sales-forecast-by-drug-type/
IQVIA. "Adjusted Pharmaceutical Sales Forecast in South Korea in 2020, by Drug Type (in Billion South Korean Won)." Statista, Statista Inc., 31 Mar 2020, https://www.statista.com/statistics/1120102/south-korea-pharmaceutical-sales-forecast-by-drug-type/
IQVIA, Adjusted pharmaceutical sales forecast in South Korea in 2020, by drug type (in billion South Korean won) Statista, https://www.statista.com/statistics/1120102/south-korea-pharmaceutical-sales-forecast-by-drug-type/ (last visited July 06, 2022)